---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030966"
form_type: "8-K"
ticker: "PURE"
cik: "0001006028"
company_name: "PURE BIOSCIENCE, INC."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:18:00.475127+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Pure Bioscience increases authorized common shares from 150M to 200M

## Summary
- Shareholders approved the amendment at the Feb 21, 2024 annual meeting.
- Certificate of Amendment filed with Delaware on Aug 5, 2024, effective immediately.
- Authorized common stock increased by 50 million shares (33% increase).

## SEC filing metadata
- accession: 0001493152-24-030966
- form_type: 8-K
- ticker: PURE
- cik: 0001006028
- company_name: PURE BIOSCIENCE, INC.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/0001493152-24-030966-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1006028/000149315224030966/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030966
- JSON: https://secwatch.observer/filing/0001493152-24-030966.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030966.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.